transdermal drug delivery market - azoth analytics...2018/11/29 · 5. transdermal drug delivery...

Global Transdermal Drug Delivery System Market: Analysis By Type

(Patches, Gels), By Technique (Ionophoresis, Electroporation,

Sonophoresis, Others), By End-User, By Region, By Country (2018 Edition):

Trends, Opportunities and Forecast (2013-2023)

• By End User- Hospital & Clinic, Healthcare

• By Region - North America, Europe, Asia

Pacific and ROW.

• By Country - U.S, Canada, U.K, Germany,

Japan, India, China , Brazil.

November 2018 1

2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

Glo

bal

Market (By Value)

By Type, By Value

Patches

Gels

By Technique, By Value

Iontophoresis

Electroporation

Sonophoresis

Others

By End User Hospital & Clinic

Homecare

Reg

ion

al

By Type, By Value

Patches

Gels


Iontophoresis

Electroporation

Sonophoresis

Others


Homecare

Co

un

try

By Type, By Value

Patches

Gels


Iontophoresis

Electroporation

Sonophoresis

Others


Homecare

Company Analysis

3 M Pharmaceutical, Boehringer Ingelheim, Mylan, Novartis, GlaxoSmithKline, Noven, Lohmann Therapeutic Systems, Johnson& Johnson,, Bayer, Corium International.

Regional Analysis North America, Europe, APAC and ROW

Country Analysis U.S, Canada, India, China,Germany, U.K., Brazil and Japan

Historical Forecast

Scope of the Report – Transdermal Drug Delivery System Market

2

Table of Content

S.No Particulars Page No.

1. Research Methodology 23

2. Executive Summary 24

3. Strategic Recommendation 25

3.1 Increase bioavailability of poor penetration drugs and increase application of transdermal drug delivery system

26

3.2 APAC region to witness augmented growth in the forecast period 27

4. Transdermal Drug Delivery System Outlook 28

5. Transdermal Drug Delivery System Market: Growth and Forecast 37

5.1 By Value (2013-2017) 38

5.2 By Value (2018-2023) 39

6. Transdermal Drug Delivery System Market: Segmental Analysis 49

6.1 Transdermal Drug Delivery System Market Size, By Type: Breakdown (%) 49

6.1.1 Transdermal Drug Delivery System Market Size, By Type, 2017 (%) 51

6.1.2 Transdermal Drug Delivery System Market Size, By Type, 2023 (%) 52

6.2 Global Patches Type Market Size, By Value (2013-2023) 53

6.3 Global Gels Type Market Size, By Value (2013-2023) 54

3

Table of Content


6.4 Global Transdermal Drug Delivery System Market Size, By Technique : Breakdown(%) 55

6.4.1 Transdermal Drug Delivery System Market Size, By Technique, 2017 (%) 56

6.4.2 Transdermal Drug Delivery System Market Size, By Technique, 2023 (%)

57

6.5 Global Iontophoresis Technique TDDS Market Size, By Value (2013-2023) 58

6.6 Global Electroporation Technique TDDS Market Size, By Value (2013-2023) 59

6.7 Global Sonophoresis Technique TDDS Market Size, By Value (2013-2023) 60

6.8 Global Others Technique TDDS Market Size, By Value (2013-2023) 61

6.9 Global Transdermal Drug Delivery System Market Size, By End User: Breakdown (%) 62

6.9.1 Transdermal Drug Delivery System System Market Size, By End User, 2017 (%) 63

6.9.2 Transdermal Drug Delivery System System Market Size, By End User , 2023 (%) 64

6.10 Global Hospital & Clinic Transdermal Drug Delivery System Market Size, By Value (2013-2023) 65

6.11 Global Homecare Transdermal Drug Delivery System Market Size, By Value (2013-2023) 66

7. Transdermal Drug Delivery System Market: Regional Analysis 67

7.1 Transdermal Drug Delivery System Market Size, By Region : Breakdown (%) 68

7.1.1 Transdermal Drug Delivery System Market Size, By Region, 2017 (%) 69

4

Table of Content


7.1.2 Transdermal Drug Delivery System Market Size, By Region, 2023 (%) 70

7.2 North America Transdermal Drug Delivery System Market: Growth and Forecast 71

7.2.1 By Value (2013-2017) 72

7.2.2 By Value (2018-2023) 73

7.2.3 By Type, By Value (2013-2017) 78

7.2.4 By Type, By Value (2018-2023) 79

7.2.5 By Technique, By Value (2013-2017) 80


7.2.7 By End User, By Value (2013-2017) 82


7.3 North America Transdermal Drug Delivery System Market: Country Analysis (U.S and Canada) 84

7.3.1 U.S. Transdermal Drug Delivery System Market, By Value (2013-2023) 86

7.3.2 U.S. Transdermal Drug Delivery System Market, By Type, By Value (2013-2017) 92

7.3.3 U.S. Transdermal Drug Delivery System Market, By Type, By Value (2018-2023) 93

7.3.4 U.S. Transdermal Drug Delivery System Market, By Technique, By Value (2013-2017) 94

5

Table of Content


7.3.5 U.S. Transdermal Drug Delivery System Market, By Technique, By Value (2018-2023) 95

7.3.6 U.S. Transdermal Drug Delivery System Market, By End User, By Value (2013-2017) 97

7.3.7 U.S. Transdermal Drug Delivery System Market, By End User, By Value (2018-2023) 98

7.3.8 Canada Transdermal Drug Delivery System Market, By Value (2013-2023) 100

7.3.9 Canada Transdermal Drug Delivery System Market, By Type, By Value (2013-2017) 104

7.3.10 Canada Transdermal Drug Delivery System Market, By Type, By Value (2018-2023) 105

7.3.11 Canada Transdermal Drug Delivery System Market, By Technique, By Value (2013-2017) 106

7.3.12 Canada Transdermal Drug Delivery System Market, By Technique, By Value (2018-2023) 107

7.3.13 Canada Transdermal Drug Delivery System Market, By End User, By Value (2013-2017) 109

7.3.14 Canada Transdermal Drug Delivery System Market, By End User, By Value (2018-2023) 110

7.4 Europe Transdermal Drug Delivery System Market: Growth and Forecast 113

7.4.1 By Value (2013-2017) 114

7.4.2 By Value (2018-2023) 115

7.4.3 By Type, By Value (2013-2017) 120

7.4.4 By Type, By Value (2018-2023) 121

6

Table of Content

S.No Page No.





7.5 Europe Transdermal Drug Delivery System Market: Country Analysis (U.K and Germany) 127

7.5.1 U.K. Transdermal Drug Delivery System Market, By Value (2013-2023) 129

7.5.2 U.K. Transdermal Drug Delivery System Market, By Type, By Value (2013-2017) 133

7.5.3 U.K. Transdermal Drug Delivery System Market, By Type, By Value (2018-2023) 134

7.5.4 U.K. Transdermal Drug Delivery System Market, By Technique, By Value (2013-2017) 135

7.5.5 U.K. Transdermal Drug Delivery System Market, By Technique, By Value (2018-2023) 136

7.5.6 U.K. Transdermal Drug Delivery System Market, By End User, By Value (2013-2017) 138

7.5.7 U.K. Transdermal Drug Delivery System Market, By End User, By Value (2018-2023) 139

7.5.8 Germany Transdermal Drug Delivery System Market, By Value (2013-2023) 141

7.5.9 Germany Transdermal Drug Delivery System Market, By Type, By Value (2013-2017) 146

7.5.10 Germany Transdermal Drug Delivery System Market, By Type, By Value (2018-2023) 147

7

Table of Content

S.No Page No.

7.5.11 Germany Transdermal Drug Delivery System Market, By Technique, By Value (2013-2017) 148

7.5.12 Germany Transdermal Drug Delivery System Market, By Technique, By Value (2018-2023) 149

7.5.13 Germany Transdermal Drug Delivery System Market, By End User, By Value (2013-2017) 151

7.5.14 Germany Transdermal Drug Delivery System Market, By End User, By Value (2018-2023) 152

7.6 APAC Transdermal Drug Delivery System Market: Growth and Forecast 154

7.6.1 By Value (2013-2017) 155

7.6.2 By Value (2018-2023) 156

7.6.3 By Type, By Value (2013-2017) 161

7.6.4 By Type, By Value (2018-2023) 162



7.6.7 By End user, By Value (2013-2017) 165

7.6.8 By End user, By Value (2018-2023) 165

7.7 APAC Transdermal Drug Delivery System Market: Country Analysis (Japan, India and China) 167

7.7.1 Japan Transdermal Drug Delivery System Market, By Value (2013-2023) 167

8

Table of Content


7.7.2 Japan Transdermal Drug Delivery System Market, By Type, By Value (2013-2017) 175

7.7.3 Japan Transdermal Drug Delivery System Market, By Type, By Value (2018-2023) 176

7.7.4 Japan Transdermal Drug Delivery System Market, By Technique, By Value (2013-2017) 177

7.7.5 Japan Transdermal Drug Delivery System Market, By Technique, By Value (2018-2023) 178

7.7.4 Japan Transdermal Drug Delivery System Market, By End user, By Value (2013-2017) 180

7.7.5 Japan Transdermal Drug Delivery System Market, By End user, By Value (2018-2023) 181

7.7.6 India Transdermal Drug Delivery System Market, By Value (2013-2023) 183

7.7.7 India Transdermal Drug Delivery System Market, By Type, By Value (2013-2017) 189

7.7.8 India Transdermal Drug Delivery System Market, By Type, By Value (2018-2023) 190

7.7.9 India Transdermal Drug Delivery System Market, By Technique, By Value (2013-2017) 191

7.7.10 India Transdermal Drug Delivery System Market, By Technique, By Value (2018-2023) 192

7.7.11 India Transdermal Drug Delivery System Market, By End user,, By Value (2013-2017) 194

7.7.12 India Transdermal Drug Delivery System Market, By End user, By Value (2018-2023) 195

7.7.13 China Transdermal Drug Delivery System Market, By Value (2013-2023) 197

7.7.14 China Transdermal Drug Delivery System Market, By Type, By Value (2013-2017) 202

9

Table of Content


7.7.15 China Transdermal Drug Delivery System Market, By Type, By Value (2018-2023) 203

7.7.16 China Transdermal Drug Delivery System Market, By Technique, By Value (2013-2017) 204

7.7.17 China Transdermal Drug Delivery System Market, By Technique, By Value (2018-2023) 205

7.7.18 China Transdermal Drug Delivery System Market, By End User, By Value (2013-2017) 207

7.7.19 China Transdermal Drug Delivery System Market, By End User, By Value (2018-2023) 208

7.8 ROW Transdermal Drug Delivery System Market: Growth and Forecast 211

7.8.1 By Value (2013-2017) 211

7.8.2 By Value (2018-2023) 211

7.8.3 By Type, By Value (2013-2017) 216

7.8.4 By Type, By Value (2018-2023) 217





7.9 ROW Transdermal Drug Delivery System Market: Country Analysis (Brazil) 223

10

Table of Content

S. No. Particulars Page No.

7.9.1 Brazil Transdermal Drug Delivery System Market, By Value (2013-2023) 224

7.9.2 Brazil Transdermal Drug Delivery System Market, By Type, By Value (2013-2017) 227

7.9.3 Brazil Transdermal Drug Delivery System Market, By Type, By Value (2018-2023) 228

7.9.4 Brazil Transdermal Drug Delivery System Market, By Technique, By Value (2013-2017) 229

7.9.5 Brazil Transdermal Drug Delivery System Market, By Technique, By Value (2018-2023) 230

7.9.6 Brazil Transdermal Drug Delivery System Market, By End User, By Value (2013-2017) 232

7.9.7 Brazil Transdermal Drug Delivery System Market, By End User, By Value (2018-2023) 233

8. Transdermal Drug Delivery System Market Dynamics 234

8.1 Transdermal Drug Delivery System Market Drivers 235

8.2 Transdermal Drug Delivery System Market Restraints 240

8.3 Transdermal Drug Delivery System Market Trends 243

9. Porter Five Force Analysis 247

10. SWOT Analysis 249

11. Supply Chain Analysis 251

12. Policy and Regulatory Landscape 253

11

Table of Content


13. Company Profiling 262

13.1 3 M Pharmaceutical 263

13.2 Boehringer Ingelheim 265

13.3 Mylan 267

13.4 Novartis 269

13.5 GlaxoSmithKline 271

13.6 Noven 273

13.7 Lohmann Therapeutics System 274

13.8 Johnson & Johnson 275

13.9 Bayer AG 277

13.10 Corium International 279

14. About Us 280

12

List of Figures

Figure No. Figure Title Page No.

Figure 1: Key Facts on Global Health Risk Diseases 36

Figure 2: Global Transdermal Drug Delivery System System Market Size, By Value, 2013-2017 (USD Billion) 38

Figure 3: Global Transdermal Drug Delivery System System Market Size, By Value, Forecast, 2018-2023 (USD Billion) 39

Figure 4: Prevalence of hypertension, By Region, 2018( In %) 42

Figure 5: Worldwide projection of Alzheimer prevalence 2005-2050 (In Million) 43

Figure 6: Distribution of Cardiovascular disease deaths, 2015 (In %) 43

Figure 7: Consequences of uncontrolled hypertension 44

Figure 8: Prevalence of Smoking, By Country, 2016 (In %) 45

Figure 9: Distribution of Abortions across Globe, 2015 (In %) 46

Figure 10: GDP Per Capita PPP, By Region, 2018 (in Thousand USD) 47

Figure 11: GDP Per Capita PPP, By Select Countries, 2022F (USD) 47

Figure 12: Healthcare Expenditure (Share of GDP), By Select Country, 2013-2017 (In %) 48

Figure 13: Transdermal Drug Delivery System System Market Size, By Type, 2017 (In %) 51

Figure 14: Transdermal Drug Delivery System System Market Size, By Type, 2023 (In %) 52

Figure 15: Global Patches Type Market, By Value, 2013-2017 (USD Billion) 53

Figure 16: Global Patches Type Market, By Value, Forecast, 2018-2023(USD Billion) 53

Figure 17: Global Gels Type Market, By Value, 2013-2017 (USD Billion) 54

Figure 18: Global Gels Type Market, By Value, Forecast, 2018-2023(USD Billion) 54

Figure 19: Transdermal Drug Delivery System Market Size, By Technique, 2017 (In %) 56

Figure 20: Transdermal Drug Delivery System System Market Size, By Technique, 2023 (In %) 57

13

List of Figures Figure No. Figure Title Page No.

Figure 21: Global Iontophoresis Technique TDDS Market, By Value, 2013-2017 (USD Billion) 58

Figure 22: Global Iontophoresis Technique TDDS Market, By Value, Forecast, 2018-2023(USD Billion) 58

Figure 23: Global Electroporation Technique Market, By Value, 2013-2017 (USD Billion) 59

Figure 24: Global Electroporation Technique Market, By Value, Forecast, 2018-2023(USD Billion) 59

Figure 25: Global Sonophoresis Technique Market, By Value, 2013-2017 (USD Billion) 60

Figure 26: Global Sonophoresis Technique Market, By Value, Forecast, 2018-2023(USD Billion) 60

Figure 27: Global Other Techniques Market, By Value, 2013-2017 (USD Billion) 61

Figure 28: Global Other Techniques Market, By Value, Forecast, 2018-2023(USD Billion) 61

Figure 29: Transdermal Drug Delivery System Market Size, By End User, 2017 (In %) 63

Figure 30: Transdermal Drug Delivery System Market Size, By End User, 2023 (In %) 64

Figure 31: Global Hospital & Clinic Transdermal Drug Delivery System Market, By Value, 2013-2017 (USD Billion) 65

Figure 32: Global Hospital & Clinic Transdermal Drug Delivery System Market, By Value, Forecast, 2018-2023(USD Billion)

65

Figure 33: Global Homecare Transdermal Drug Delivery System Market, By Value, 2013-2017 (USD Billion) 66

Figure 34: Global Homecare Transdermal Drug Delivery System Market, By Value, Forecast, 2018-2023 (USD Billion) 66

Figure 35: Global Healthcare Landscape, By Select Region 68

Figure 36: Transdermal Drug Delivery System Market Size, By Region, 2017 (In %) 69

Figure 37: Transdermal Drug Delivery System Market Size, By Region, 2023 (In %) 70

Figure 38: North America Transdermal Drug Delivery System Market Size, By Value, 2013-2017 (USD Billion) 72

Figure 39: North America Transdermal Drug Delivery System Market Size, By Value, Forecast, 2018-2023 (USD Billion) 73

Figure 40: North America Healthcare Cost Per Capita, 2017 (USD) 74

14

List of Figures


Figure 41: North America Population Ages 65 and above, 2012-2017 (% of Total) 74

Figure 42: North America GDP, 2012-2017 (USD Trillion) 75

Figure 43: North America GDP per capita, current prices, 2013-2023F (In USD) 75

Figure 44: North America Transdermal Drug Delivery System Market: By Type, By Value, 2013-2017 (USD Billion) 78

Figure 45: North America Transdermal Drug Delivery System Market: By Type, By Value, 2018E-2023F (USD Billion) 79

Figure 46: North America Transdermal Drug Delivery System Market: By Technique , By Value, 2013-2017 (USD Billion)

80

Figure 47: North America Transdermal Drug Delivery System Market: By Technique, By Value, 2018E-2023F (USD Billion)

81

Figure 48: North America Transdermal Drug Delivery System Market: By End User, By Value, 2013-2017 (USD Billion) 82

Figure 49: North America Transdermal Drug Delivery System Market: By End User, By Value, 2018E-2023F (USD Billion)

83

Figure 50: U.S. Transdermal Drug Delivery System Market Size, By Value, 2013-2023 (USD Billion) 86

Figure 51: U.S., Per Capita Expenditure on Healthcare, 2012-2018E (In USD) 88

Figure 52: U.S., Population ages 65 and above, 2013-2017 (% of total) 89

Figure 53: U.S., Population ages 65 and above, Forecast (In Billions) 89

Figure 54: U.S., Diseases developed by smoking addicts (in number) 90

Figure 55: U.S., GDP (Current USD), 2013-2017 (In USD Trillion) 90

Figure 56: U.S. Transdermal Drug Delivery System Market: By Type, By Value, 2013-2017 (USD Billion) 92

Figure 57: U.S. Transdermal Drug Delivery System Market: By Type, By Value, 2018-2023 (USD Billion) 93

Figure 58: U.S. Transdermal Drug Delivery System Market: By Technique , By Value, 2013-2017 (USD Billion) 94

Figure 59: U.S. Transdermal Drug Delivery System Market: By Technique , By Value, 2018-2023 (USD Billion) 95

Figure 60: U.S. Transdermal Drug Delivery System Market: By End User, By Value, 2013-2017 (USD Billion) 97

15

List of Figures

Figure No. Figure Title

Page No.

Figure 61: U.S. Transdermal Drug Delivery System Market: By End User, By Value, 2018E-2023F (USD Billion) 98

Figure 62: Canada Transdermal Drug Delivery System Market Size, By Value, 2013-2023 (USD Billion) 100

Figure 63: Canada, Expenditure on Health as a share of GDP, 2012-2017 (in %) 102

Figure 64: Canada, Per Capita Healthcare Expenditure, 2012-2017 (USD) 102

Figure 65: Canada, Population ages 65 and above, 2012-2017 (% of total) 102

Figure 66: Canada Transdermal Drug Delivery System Market: By Type, By Value, 2013-2017 (USD Billion) 104

Figure 67: Canada Transdermal Drug Delivery System Market: By Type, By Value, 2018-2023 (USD Billion) 105

Figure 68: Canada Transdermal Drug Delivery System Market: By Technique , By Value, 2013-2017 (USD Billion) 106

Figure 69: Canada Transdermal Drug Delivery System Market: By Technique , By Value, 2018-2023 (USD Billion) 107

Figure 70: Canada Transdermal Drug Delivery System Market: By End User, By Value, 2013-2017 (USD Billion) 109

Figure 71: Canada Transdermal Drug Delivery System Market: By End User, By Value, 2018E-2023F (USD Billion) 110

Figure 72: North America Transdermal Drug Delivery System Market, Country Share, 2013-2017E (% of Total) 112

Figure 73: North America Transdermal Drug Delivery System Market, Country Share, 2018F-2023F (% of Total) 112

Figure 74: Europe Transdermal Drug Delivery System Market Size, By Value, 2013-2017 (USD Billion) 114

Figure 75: Europe Transdermal Drug Delivery System Market Size, By Value, Forecast, 2018-2023 (USD Billion) 115

Figure 76: Per Capita Health Expenditure, By Select Country, 2017 (USD) 117

Figure 77: European Union, Population ages 65 and above, 2013-2017 (% of total) 117

Figure 78: European Country Population Aged 65 and Above, 2012-2017 (% of Total) 118

Figure 79: GDP, Europe Region, By Select Country, 2017 (In Trillion USD) 118

Figure 80: Europe Transdermal Drug Delivery System Market: By Type, By Value, 2013-2017 (USD Billion) 120

16

List of Figures


Figure 81: Europe Transdermal Drug Delivery System Market: By Product, By Value, 2018E-2023F (USD Billion) 121

Figure 82: Europe Transdermal Drug Delivery System Market: By Technique , By Value, 2013-2017 (USD Billion) 122

Figure 83: Europe Transdermal Drug Delivery System Market: By Technique , By Value, 2018-2023 (USD Billion) 123

Figure 84: Europe Transdermal Drug Delivery System Market: By End User, By Value, 2013-2017 (USD Billion) 125

Figure 85: Europe Transdermal Drug Delivery System Market: By End User, By Value, 2018E-2023F (USD Billion) 126

Figure 86: U.K. Transdermal Drug Delivery System Market Size, By Value, 2013-2023 (USD Billion) 129

Figure 87: U.K, Health Expenditure Per Capita, PPP, 2012-2017 (USD) 131

Figure 88: U.K, Population Ages 65 and Above (% of total), 2012-2017 131

Figure 89: U.K. Transdermal Drug Delivery System Market: By Type, By Value, 2013-2017 (USD Billion) 133

Figure 90: U.K. Transdermal Drug Delivery System Market: By Type, By Value, 2018-2023 (USD Billion) 134

Figure 91: U.K. Transdermal Drug Delivery System Market: By Technique , By Value, 2013-2017 (USD Billion) 135

Figure 92: U.K. Transdermal Drug Delivery System Market: By Technique , By Value, 2018-2023 (USD Billion) 136

Figure 93: U.K. Transdermal Drug Delivery System Market: By End User, By Value, 2013-2017 (USD Billion) 138

Figure 94: U.K. Transdermal Drug Delivery System Market: By End User, By Value, 2018E-2023F (USD Billion) 139

Figure 95: Germany Transdermal Drug Delivery System Market Size, By Value, 2013-2023 (USD Billion) 141

Figure 96: Germany, Age Structure Breakdown, 2017 (In %) 143

Figure 97: Germany, Health Expenditure Per Capita, PPP, 2012-2017 (USD) 144

Figure 98: Germany, Population ages 65 and above, 2012-2017 (% total) 144

Figure 99: Germany Transdermal Drug Delivery System Market: By Type, By Value, 2013-2017 (USD Billion) 146

Figure 100: Germany Transdermal drug Delivery System Market: By Type, By Value, 2018-2023 (USD Billion) 147

17

List of Figures


Figure 101: Germany Transdermal Drug Delivery System Market: By Technique , By Value, 2013-2017 (USD Billion) 148

Figure 102: Germany Transdermal Drug Delivery System Market: By Technique , By Value, 2018-2023 (USD Billion) 149

Figure 103: Germany Transdermal Drug Delivery System Market: By End User, By Value, 2013-2017 (USD Billion) 151

Figure 104: Germany Transdermal Drug Delivery System Market: By End User, By Value, 2018E-2023F (USD Billion) 152

Figure 105: Europe Transdermal Drug Delivery System Market, Country Share, Historic, 2013-2017(% of Total) 153

Figure 106: Europe Transdermal Drug Delivery System Market, Country Share, Forecast, 2018-2023 (% of Total) 153

Figure 107: APAC Transdermal Drug Delivery System Market Size, By Value, 2013-2017 (USD Billion) 155

Figure 108: APAC Transdermal Drug Delivery System Market Size, By Value, Forecast, 2018-2023 (USD Billion) 156

Figure 109: APAC, GDP, By Select Country, 2017 (In USD Trillion) 158

Figure 110: Population ages 65 and above, APAC Region, By Select Countries, 2017 (% of total) 159

Figure 111: Population ages 65 and above, APAC Region, By Select Countries, 2050 (% of total) 159

Figure 112: APAC Transdermal Drug Delivery System Market: By Type, By Value, 2013-2017 (USD Billion) 162

Figure 113: APAC Transdermal Drug Delivery System Market: By Type, By Value, 2018E-2023F (USD Billion) 163

Figure 114: APAC Transdermal Drug Delivery System Market: By Technique , By Value, 2013-2017 (USD Billion) 164

Figure 115: APAC Transdermal Drug Delivery System Market: By Technique , By Value, 2018-2023 (USD Billion) 165

Figure 116: APAC Transdermal Drug Delivery System Market: By End User, By Value, 2013-2017 (USD Billion) 167

Figure 117: APAC Transdermal Drug Delivery System Market: By End User, By Value, 2018E-2023F (USD Billion) 168

Figure 118: Japan Transdermal Drug Delivery System Market Size, By Value, 2013-2023 (USD Billion) 171

Figure 119: Japan, GDP Growth Per Year, 2015-2019F (In %) 173

Figure 120: Japan Healthcare Expenditure Outlook (2016) (%) 173

18

List of Figures


Figure 121: Japan, Population ages 65 and above, 2012-2016 (% of total) 173

Figure 122: Japan Transdermal Drug Delivery System Market: By Type, By Value, 2013-2017 (USD Billion) 175

Figure 123: Japan Transdermal Drug Delivery System Market: By Type, By Value, 2018E-2023F (USD Billion) 176

Figure 124: Japan Transdermal Drug Delivery System Market: By Technique , By Value, 2013-2017 (USD Billion) 177

Figure 125: Japan Transdermal Drug Delivery System Market: By Technique , By Value, 2018-2023 (USD Billion) 178

Figure 126: Japan Transdermal Drug Delivery System Market: By End User, By Value, 2013-2017 (USD Billion) 180

Figure 127: Japan Transdermal Drug Delivery System Market: By End User, By Value, 2018E-2023F (USD Billion) 181

Figure 128: India Transdermal Drug Delivery System Market Size, By Value, 2013-2023 (USD Billion) 183

Figure 129: India, Population ages 65 and above, 2012-2017 186

Figure 130: India, Share of Urban Population, 2012-2017 (In %) 186

Figure 131: India, GDP Growth Per Year, 2015-2019 (In %) 187

Figure 132: India, Total Population, 2013-2023F (In Billion) 187

Figure 133: India Transdermal Drug Delivery System Market: By Type, By Value, 2013-2017 (USD Billion) 189

Figure 134: India Transdermal Drug Delivery System Market: By Type, By Value, 2018E-2023F (USD Billion) 190

Figure 135: India Transdermal Drug Delivery System Market: By Technique , By Value, 2013-2017 (USD Billion) 191

Figure 136: India Transdermal Drug Delivery System Market: By Technique , By Value, 2018-2023 (USD Billion) 192

Figure 137: India Transdermal Drug Delivery System Market: By End User, By Value, 2013-2017 (USD Billion) 194

Figure 138: India Transdermal Drug Delivery System Market: By End User, By Value, 2018E-2023F (USD Billion) 195

Figure 139: China Transdermal Drug Delivery System Market Size, By Value, 2013-2023 (USD Billion) 197

Figure 140: China, Population aged 65 and above, 2012-2017 (% of total) 199

19

List of Figures


Figure 141: China Healthcare Expenditure Outlook (2017) (%) 199

Figure 142: China, GDP Growth Per Year, 2015-2019 (In %) 200

Figure 143: China, Share of Urban Population, 2012-2017 (In %) 200

Figure 144: China, Total Population, 2013-2021F (In Billion) 200

Figure 145: China Transdermal Drug Delivery System Market: By Type, By Value, 2013-2017 (USD Billion) 202

Figure 146: China Transdermal Drug Delivery System Market: By Type, By Value, 2018E-2023F (USD Billion 203

Figure 147: China Transdermal Drug Delivery System Market: By Technique , By Value, 2013-2017 (USD Billion) 204

Figure 148: China Transdermal Drug Delivery System Market: By Technique , By Value, 2018-2023 (USD Billion) 205

Figure 149: China Transdermal Drug Delivery System Market: By End User, By Value, 2013-2017 (USD Billion) 207

Figure 150: China Transdermal Drug Delivery System Market: By End User, By Value, 2018E-2023F (USD Billion) 208

Figure 151: APAC Transdermal Drug Delivery System Market, Country Share, 2013-2017 (% of Total) 209

Figure 152: APAC Transdermal Drug Delivery System Market, Country Share, 2018-2023 (% of Total) 209

Figure 153: ROW Transdermal Drug Delivery System Market Size, By Value, 2013-2023 (USD Billion) 211

Figure 154: Latin America and Caribbean, Population ages 65 and above (% of total) 213

Figure 155: Latin America and Caribbean, Share of Urban Population in Total Population, 2012-2017 (In %) 213

Figure 156: Latin America and Caribbean, Share of Urban Population in Total Population, 2012-2017 (In %) 214

Figure 157: Middle East and North Africa, GDP, 2012-2017 (In USD Trillion) 214

Figure 158: ROW Transdermal Drug Delivery System Market: By Type, By Value, 2013-2017 (USD Billion) 216

Figure 159: ROW Transdermal Drug Delivery System Market: By Type, By Value, 2018E-2023F (USD Billion) 217

Figure 160: ROW Transdermal Drug Delivery System Market: By Technique , By Value, 2013-2017 (USD Billion) 218

20

List of Figures


Figure 161: ROW Transdermal Drug Delivery System Market: By Technique , By Value, 2018-2023 (USD Billion) 219

Figure 162: ROW Transdermal Drug Delivery System Market: By End User, By Value, 2013-2017 (USD Billion) 221

Figure 163: ROW Transdermal Drug Delivery System Market: By End User, By Value, 2018E-2023F (USD Billion) 222

Figure 164: Brazil Transdermal Drug Delivery System Market Size, By Value, 2013-2023 (USD Billion) 224

Figure 165: Brazil, Population ages 65 and above, 2012-17 (% of total) 225

Figure 166: Brazil, GDP, 2012-2017 (In USD Trillion) 225

Figure 167: Brazil Transdermal Drug Delivery System Market: By Type, By Value, 2013-2017 (USD Billion) 227

Figure 168: Brazil Transdermal Drug Delivery System Market: By Type, By Value, 2018E-2023F (USD Billion) 228

Figure 169: Brazil Transdermal Drug Delivery System Market: By Technique , By Value, 2013-2017 (USD Billion) 229

Figure 170: Brazil Transdermal Drug Delivery System Market: By Technique , By Value, 2018-2023 (USD Billion) 230

Figure 171: Brazil Transdermal Drug Delivery System Market: By End User, By Value, 2013-2017 (USD Billion) 232

Figure 172: Brazil Transdermal Drug Delivery System Market: By End user, By Value, 2018E-2023F (USD Billion) 233

Figure 173: 3 M Pharmaceutical, Net Sales, 2013-2017 (In Billion USD) 264

Figure 174: 3 M Pharmaceutical, Net Sales, By Business Sector, 2017 (In %) 264

Figure 175: 3 M Pharmaceutical, Net Sales, By Geographic Region, 2017 (In %) 264

Figure 176: Boehringer Ingelheim, Net Sales, 2013-2017 (In Billion USD) 266

Figure 177: Boehringer Ingelheim, Net Sales, By Business Sector, 2017 (In %) 266

Figure 178: Boehringer Ingelheim, Net Sales, By Geographic Region, 2017 (In %) 266

Figure 179: Mylan, Sales Revenue, 2013-2017 (In USD Billion) 268

Figure 180: Mylan , Sales, By Business Segment, 2017 (In %) 268

21

List of Figures


Figure 181: Mylan , By Geographic Region, 2017 In (%) 268

Figure 182: Novartis, Sales Revenue, 2013-2017 (In USD Billion) 270

Figure 183: Novartis, Sales, By Business Segment, 2017 (In %) 270

Figure 184: Novartis, By Geographic Region, 2017 In (%) 270

Figure 185: GlaxoSmithKline, Sales Revenue, 2013-2017 (In USD Billion) 272

Figure 186: GlaxoSmithKline, Sales, By Business Segment, 2017 (In %) 272

Figure 187: GlaxoSmithKline, By Geographic Region, 2017 In (%) 272

Figure 188: Johnson& Johnson, Sales Revenue, 2013-2017 (In USD Billion) 276

Figure 189: Johnson & Johnson, Sales, By Business Segment, 2017 (In %) 276

Figure 190: Johnson & Johnson, By Geographic Region, 2017 In (%) 276

Figure 191: Bayer, Sales Revenue, 2013-2017 (USD Billion) 278

Figure 192: Bayer, Sales Revenue, 2013-2017 (USD Billion) 278

Figure 193: Bayer , Sales, By Geographic region, FY ended March 2017 (%) 278

Table A: Parameters affecting selection of drugs in TDDS 30

Table B: Germany, Healthcare Related Statistics, 2017 143

Table C: Global Access to Healthcare Index, Ranking of Select Countries in Asia Pacific Region, 2017 (score out of 10) 160

22

For our study on Transdermal Drug Delivery System Market, we have conducted comprehensive secondary

research followed by an extensive primary research. In the process of secondary research, we have

scrutinized industry documents, accessed from open sources, premium paid databases (Bloomberg, Thomson

Reuters, Factiva) and our internal knowledge base. In the process of primary research, we have interviewed

various industry experts across the value chain of medical device industry.

Market size of the actual period (2013-2017) has been evaluated on the basis of growth trends of the

industry in the last five years, and confirming the findings through primary research. Annual reports of the

companies were scanned to further validate the market size and to estimate the size of various other end-

user sectors. Market sizing and growth in the forecast period (2018-2023) is estimated through product

mapping, application in end-user industries, growth of allied sectors and historical growth pattern of the

industry. All the relevant data points/ statistics in the forecast period are validated through relevant and

reliable primary sources.

Report Focus: Transdermal Drug Delivery System Market

- By Type (Patches, Gels)

- By Technique(Iontophoresis, Electroporation, Sonophoresis and Others)

- By End User- (Hospital & Clinic, Homecare)

- By Region (North America, Europe, Asia Pacific and Rest of the World)

- By Country ( U.S., Canada, U.K, Germany, India, China, Japan and Brazil).

Companies Contacted: GlaxoSmithKline, Fortis Hospital

Research Methodology

23

Global Transdermal Drug Delivery System Market

Xx

Xx

Xx

Xx

Xx

Xx

2013 2014 2015 2016 2017

Source: Azoth Analytics Estimates

CAGR 2013-2017

xx%

Figure 2: Global Transdermal Drug Delivery System System Market Size, By Value, 2013-2017 (USD Billion)

Manifested cure for diseases, having threatening consequences, has been driving the demand growth in

historic period.

24

Global Transdermal Drug Delivery System Market

Increase in research and development along with growing generic market for transdermal drugs is likely

to drive the demand growth in forecast period.

2018 2019 2020 2021 2022 2023


CAGR 2018-2023

xx%

Figure 3: Global Transdermal Drug Delivery System System Market Size, By Value, Forecast, 2018-2023 (USD Billion)

25

Xx

Xx

Xx

Xx

Xx

Xx

Global Trandermal Drug Delivery Systems Replacement Devices Market, By Value

Figure 15: Global Patches Type Market, By Value, 2013-

2017 (USD Billion)


CAGR 2013-2017

xx%

CAGR 2018-2023

xx%

Figure 16: Global Patches Type Market, By Value, Forecast,

2018-2023(USD Billion)

2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

Global Transdermal Drug Market, By Patches

Xx

Xx

Xx

Xx

Xx

Xx

Xx

26


Figure 17: Global Gels Type Market, By Value, 2013-

2017 (USD Billion)


Figure 18: Global Gels Type Market, By Value,

Forecast, 2018-2023(USD Billion)

Global Transdermal Drug Market, By Gels

27

CAGR 2013-2017

xx%

CAGR 2018-2023

xx%

2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

Xx

Xx

Xx

Xx

Xx

Xx

Xx


Figure 21: Global Iontophoresis Technique TDDS

Market, By Value, 2013-2017 (USD Billion)


Figure 22: Global Iontophoresis Technique TDDS Market,

By Value, Forecast, 2018-2023(USD Billion)

Global Transdermal Drug Market, By Technique (Iontophoresis)

28

CAGR 2013-2017

xx%

CAGR 2018-2023

xx%

2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

Xx

Xx

Xx

Xx

Xx

Xx

Xx


Figure 23: Global Electroporation Technique Market, By

Value, 2013-2017 (USD Billion)


Figure 24: Global Electroporation Technique Market, By

Value, Forecast, 2018-2023(USD Billion)

Global Transdermal Drug Market, By Technique (Electroporation)

29

CAGR 2013-2017

xx%

CAGR 2018-2023

xx%

2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

Xx

Xx

Xx

Xx

Xx

Xx

Xx


Figure 25: Global Sonophoresis Technique Market, By

Value, 2013-2017 (USD Billion)


Figure 26: Global Sonophoresis Technique Market, By

Value, Forecast, 2018-2023(USD Billion)

Global Transdermal Drug Market, By Technique (Sonophoresis)

30

CAGR 2013-2017

xx%

CAGR 2018-2023

xx%

2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

Xx

Xx

Xx

Xx

Xx

Xx

Xx


Figure 27: Global Other Techniques Market, By Value,

2013-2017 (USD Billion)


Figure 28: Global Other Techniques Market, By Value,

Forecast, 2018-2023(USD Billion)

Global Transdermal Drug Market, By Technique (Others)

31

CAGR 2013-2017

xx%

CAGR 2018-2023

xx%

2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

Xx

Xx

Xx

Xx

Xx

Xx

Xx


Figure 31: Global Hospital & Clinic Transdermal Drug

Delivery System Market, By Value, 2013-2017 (USD Billion)


Figure 32: Global Hospital & Clinic Transdermal Drug Delivery

System Market, By Value, Forecast, 2018-2023(USD Billion)

Global Hospital Transdermal Drug Delivery System Market

32

CAGR 2013-2017

xx%

CAGR 2018-2023

xx%

2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

Xx

Xx

Xx

Xx

Xx

Xx

Xx


Figure 33: Global Homecare Transdermal Drug Delivery

System Market, By Value, 2013-2017 (USD Billion)


Figure 34: Global Homecare Transdermal Drug Delivery System

Market, By Value, Forecast, 2018-2023 (USD Billion)

Global Homecare Transdermal Dug Delivery System Market

33

CAGR 2013-2017

xx%

CAGR 2018-2023

xx%

2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

Xx

Xx

Xx

Xx

Xx

Xx

Xx

North America Transdermal Drug Delivery System Market Overview


Growing prevalence of CVD diseases, stress, hormonal disturbance and increased per capita expenditure

on healthcare has been driving regional demand .

Figure 38: North America Transdermal Drug Delivery System Market Size, By Value, 2013-2017 (USD Billion)

34

Xx

Xx

Xx

Xx

Xx

Xx

2013 2014 2015 2016 2017

CAGR 2013-2017

xx%

North America Transdermal Drug Delivery System Market Overview

Concentration of major companies in the region as well as partnerships and collaboration with

key players is anticipated to drive the market.


Figure 39: North America Transdermal Drug Delivery System Market Size, By Value, Forecast, 2018-2023 (USD Billion)

35

Xx

Xx

Xx

Xx

Xx

Xx

2018 2019 2020 2021 2022 2023

CAGR 2018-2023

xx%


Figure 44: North America Transdermal Drug Delivery System Market: By Type, By Value, 2013-2017 (USD Billion)

CAGR 2013-2017

Patches: xx%

Gels: xx%

North America Transdermal Drug Delivery System Market, By Type

2013 2014 2015 2016 2017

Patches xx xx xx xx xx

Gels xx xx xx xx xx

2013 2014 2015 2016 2017

Patches Gels

Xx

Xx

Xx

Xx

36


Figure 45: North America Transdermal Drug Delivery System Market: By Type, By Value, 2018E-2023F (USD Billion)

North America Transdermal Drug Delivery System Market, By Type

2018 2019 2020 2021 2022 2023

Patches xx xx xx xx xx xx

Gels xx xx xx xx xx xx

2018 2019 2020 2021 2022 2023

Patches Gels

Xx

Xx

Xx

CAGR 2018-2023

Patches : xx%

Gels :xx%

37


Figure 46: North America Transdermal Drug Delivery System Market: By Technique , By Value, 2013-2017 (USD Billion)

CAGR 2013-2017

Iontophoresis: xx%

Electroporation: xx%

Sonophoresis: xx%

Others: xx%

North America Transdermal Drug Delivery System Market, By Technique

2013 2014 2015 2016 2017

Iontophoresis xx xx xx xx xx

Electroporation xx xx xx xx xx

Sonophoresis xx xx xx xx xx

Others xx xx xx xx xx

2013 2014 2015 2016 2017

Iontophoresis Electroporation Sonophoresis Others

Xx

Xx

Xx

Xx

38


Figure 47: North America Transdermal Drug Delivery System Market: By Technique, By Value, 2018E-2023F (USD Billion)

North America Transdermal Drug Delivery System Market, By Technique

2018 2019 2020 2021 2022 2023Iontophoresis Electroporation Sonophoresis Others

CAGR 2013-2017

Iontophoresis: xx%


Sonophoresis: xx%

Others: xx%

2013 2014 2015 2016 2017

Iontophoresis xx xx xx xx xx xx

Electroporation xx xx xx xx xx xx

Sonophoresis xx xx xx xx xx xx

Others xx xx xx xx xx xx

Xx

Xx

Xx

Xx

39


Figure 48: North America Transdermal Drug Delivery System Market: By End User, By Value, 2013-2017 (USD Billion)

CAGR 2013-2017

Hospital & Clinic: xx% Homecare: xx%

North America Transdermal Drug Delivery System Market, By End User

2013 2014 2015 2016 2017

Hospital & Clinic xx xx xx xx xx

Homecare xx xx xx xx xx

2013 2014 2015 2016 2017

Hospital & Clinic Homecare

Xx

Xx

Xx

Xx

40


Figure 49: North America Transdermal Drug Delivery System Market: By End User, By Value, 2018E-2023F (USD Billion)

CAGR 2018-2023

Hospital & Clinic: xx%

Homecare: xx%

North America Transdermal Drug Delivery System Market, By End User

2018 2019 2020 2021 2022 2023

Hospital & Clinic xx xx xx xx xx xx

Homecare xx xx xx xx xx xx

2018 2019 2020 2021 2022 2023


Xx

Xx

Xx

Xx

41

U.S. Transdermal Drug Delivery System Market, By Value

• .


Figure 50: U.S. Transdermal Drug Delivery System Market Size, By Value, 2013-2023 (USD Billion)

42

CAGR 2013-2017

xx%

CAGR 2018-2023

xx%

2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

Xx

Xx

Xx

Xx

Xx

Xx

Xx


Figure 56: U.S. Transdermal Drug Delivery System Market: By Type, By Value, 2013-2017 (USD Billion)

U.S. Transdermal Drug Delivery System Market, By Type

43

CAGR 2013-2017

Patches: xx%

Gels: xx%

2013 2014 2015 2016 2017

Patches xx xx xx xx xx

Gels xx xx xx xx xx

2013 2014 2015 2016 2017

Patches Gels

Xx

Xx

Xx

Xx


Figure 57: U.S. Transdermal Drug Delivery System Market: By Type, By Value, 2018-2023 (USD Billion)

CAGR 2018-2023

Patches: xx%

Gels: xx%

U.S. Transdermal Drug Delivery System Market, By Type

2018 2019 2020 2021 2022 2023

Patches xx xx xx xx xx xx

Gels xx xx xx xx xx xx

2018 2019 2020 2021 2022 2023

Patches Gels

Xx

Xx

Xx

Xx

44


Figure 58: U.S. Transdermal Drug Delivery System Market: By Technique , By Value, 2013-2017 (USD Billion)

U.S. Transdermal Drug Delivery System Market, By Technique

45

CAGR 2013-2017

Iontophoresis: xx%


Sonophoresis: xx%

Others: xx%

2013 2014 2015 2016 2017

Iontophoresis xx xx xx xx xx

Electroporation xx xx xx xx xx

Sonophoresis xx xx xx xx xx

Others xx xx xx xx xx

2013 2014 2015 2016 2017



Figure 59: U.S. Transdermal Drug Delivery System Market: By Technique , By Value, 2018-2023 (USD Billion)

CAGR 2018-2023

Iontophoresis: xx%


Sonophoresis: xx%

Others: xx%

U.S. Transdermal Drug Delivery System Market, By Technique

2018 2019 2020 2021 2022 2023

Iontophoresis xx xx xx xx xx xx

Electroporation xx xx xx xx xx xx

Sonophoresis xx xx xx xx xx xx

Others xx xx xx xx xx xx

2018 2019 2020 2021 2022 2023


46

2013 2014 2015 2016 2017



Figure 60: U.S. Transdermal Drug Delivery System Market: By End User, By Value, 2013-2017 (USD Billion)

CAGR 2013-2017

Hospital & Clinic: xx%

Homecare: xx%

U.S. Transdermal Drug Delivery System Market, By End User

2013 2014 2015 2016 2017

Hospital & Clinic xx xx xx xx xx

Homecare xx xx xx xx xx

Xx

Xx

Xx

Xx

47


Figure 61: U.S. Transdermal Drug Delivery System Market: By End User, By Value, 2018E-2023F (USD Billion)

CAGR 2018-2023

Hospital & Clinic: xx% Homecare: xx%

U.S. Transdermal Drug Delivery System Market, By End User

2018 2019 2020 2021 2022 2023

Hospital & Clinic xx xx xx xx xx xx

Homecare xx xx xx xx xx xx

2018 2019 2020 2021 2022 2023


Xx

Xx

Xx

Xx

Xx

48

About Azoth Analytics Pvt Ltd.

Azoth Analytics is a business research and analytics firm that creates in-depth research reports and provides customized research solutions and consultancy services. Verticals in which Azoth Analytics specializes include healthcare and pharmaceutical, oil and gas, retail, chemicals, automotive, FMCG, food & beverages and technology. Azoth creates comprehensive and in-depth research reports by recording, interpreting and analyzing information. Strategic market sizing and data dredging Technique include secondary research, and primary research (interviews with management personnel and industry experts).

Disclaimer: Azoth Analytics report information is based mainly on interviews and therefore, is subject to fluctuation. Azoth Analytics therefore, takes no responsibility for

any incorrect information supplied to us by industry experts, manufacturers or users. Azoth does not warranty the completeness of the information and data. Also, analysis

provided in the report are meant for customers’ internal use only and not for general publication or disclosure to third parties.

49

transdermal drug delivery market - azoth analytics...2018/11/29 · 5. transdermal drug delivery...

Documents